Pharmacokinetics, efficacy, and safety of weekly/biweekly dosing of Xembify® in treatment-experienced patients, and loading/maintenance dosing in treatment-naive patients with primary immunodeficiency

被引：0
|
作者：
Lumry, William [1 ]
Palumbo, Michael [2 ]
Hsu, Connie [3 ]
Hussain, Iftikhar [4 ]
McNeil, Donald [5 ]
Bridges, Tracy [6 ]
Scarupa, Mark [7 ]
Mondou, Elsa [8 ]
Nanaware-Kharade, Nisha [8 ]
Hanna, Kim [8 ]
Liang, Jin [8 ]
Williamson, Jennifer [8 ]
Querolt-Coll, Montserrat [8 ]
Oliveras, Juan [8 ]
机构：
[1] Allergy & Asthma Res Assoc Res Ctr, Internist & Allergist, Oklahoma City, OK USA
[2] White Plains Hosp, Allergy & Clin Immunol, White Plains, NY USA
[3] Res Solut Arizona PC, Allergy & Immunol, Scottsdale, AZ USA
[4] VItal Prospects Clin Res Inst P C, Allergy Asthma & Immunol, Tulsa, OK USA
[5] Optimed Res LTD, Columbus, OH USA
[6] Georgia Pollens Clin Res Ctr INC, Allergy Asthma & Immunol, Albany, GA USA
[7] Inst Asthma & Allergy, Allergy & Immunol, Studio City, CA USA
[8] Grifols, Biosci Res Grp, Barcelona, Spain
来源：
CLINICAL IMMUNOLOGY | 2024年 / 262卷
关键词：
Subcutaneous immunoglobulin; Primary immunodeficiency; Clinical trial; Pharmacokinetics; Xembify; GC1906;
D O I：
10.1016/j.clim.2024.109989
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
47
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Pharmacokinetics of Sifuvirtide in Treatment-Naive and Treatment-Experienced HIV-Infected Patients
    Meng, Qingfang
    Dong, Tianhao
    Chen, Xin
    Tong, Baohui
    Qian, Xiaohong
    Che, Jinjing
    Cheng, Yuanguo
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 103 (12) : 4038 - 4047
  • [2] Above-Label Dosing with Biologics in Treatment-NaiVe and Treatment-Experienced Patients with Moderate-to-Severe Psoriatic Arthritis
    Schwartzman, Sergio
    Li, Yunfeng
    Zhou, Huanxue
    Herrera, Vivian
    Palmer, Jacqueline B.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [3] Efficacy and safety of sofosbuvir-based therapy for the treatment of chronic hepatitis C in treatment-naive and treatment-experienced patients
    Liu, Xi
    Wang, Yawen
    Zhang, Guanjun
    Li, Na
    Zhu, Qianqian
    Chang, Hongyun
    Han, Qunying
    Lv, Yi
    Liu, Zhengwen
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 44 (02) : 145 - 151
  • [4] Agenerase™ shows promise in treatment-naive and treatment-experienced HIV patients
    不详
    [J]. AIDS PATIENT CARE AND STDS, 1999, 13 (02) : 128 - 129
  • [5] Pharmacokinetic Analysis of Weekly Versus Biweekly IgPro20 Dosing in Patients With Primary Immunodeficiency
    Rojavin, Mikhail A.
    Chapdelaine, Hugo
    Tortorici, Michael A.
    Praus, Michaela
    Baheti, Gautam
    Zhang, Ying
    Hofmann, Jutta
    Labrosse, Roxane
    Dicaire, Renee
    Haddad, Elie
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (06): : 664 - 670
  • [6] Optimizing management of treatment-naive and treatment-experienced HIV+ patients: the role of maraviroc
    Poveda, Eva
    Soriano, Vincent
    [J]. HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2010, 2 : 51 - 58
  • [7] Efficacy of hepatic arterial infusion chemotherapy between treatment-naive and treatment-experienced patients with advanced hepatocellular carcinoma
    Yu, Hyung-Min
    Kim, Seung-Hun
    Myung, Eun
    Myung, Dea-Seong
    Cho, Sung-Bum
    Lee, Wan-Sik
    Joo, Young-Eun
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 423 - 423
  • [8] Efficacy and tolerability of stavudine plus lamivudine in treatment-naive and treatment-experienced patients with HIV-1 infection
    Katlama, C
    Valantin, MA
    Matheron, S
    Coutellier, A
    Calvez, V
    Descamps, D
    Longuet, C
    Bonmarchand, M
    Tubiana, R
    De Sa, M
    Lancar, R
    Agut, H
    Brun-Vezinet, F
    Costagliola, D
    [J]. ANNALS OF INTERNAL MEDICINE, 1998, 129 (07) : 525 - +
  • [9] THE COMPARATIVE EFFICACY OF TELAPREVIR VERSUS BOCEPREVIR IN TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS
    Diels, J.
    Cure, S.
    Gavart, S.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A266 - A266
  • [10] Population pharmacokinetic analysis of weekly and biweekly IgPro20 (Hizentra®) dosing in patients with primary immunodeficiency
    Zhang, Ying
    Baheti, Gautam
    Chapdelaine, Hugo
    Hofmann, Jutta
    Rojavin, Mikhail
    Tortorici, Michael
    Haddad, Elie
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 81
12345